Private Equity Market Spotlight

Image of an abstract representation of financial data

Accomplishments

As a group, we saw continued momentum and strong activity over the past year. Data reflects Private Equity transactions in FY25.
530+
Total Deals Across 25+ Industries
$162+ Billion
Total Deal Value (US)
385+
Private Equity Lawyers Globally
48%
of Deals Involved Founder-Owned Companies

Practice Group Expansion

FY25 also marked a period of strategic expansion for our Private Equity platform, strengthening the group’s capabilities and enhancing its ability to support clients globally. Welcome to Michael Amalfe, Matthew Ayre, Youjung Byon, Shandy Pinkowski, Tom Roberts and Patrick Sandor.

Deal Type Statistics

Deal Type Statistics

Awards & Accolades

#1 M&A Advisor
LSEG ranked Goodwin top firm by deal count for Global, Global Principal Advisors, U.S. Involvement, and U.S. Target, announced and completed.
Publications & External Recognition

Leading firm across the U.S., Europe and Asia for Private Equity, recognized by publications including Chambers and Partners, The Legal 500, IFLR 1000, Best Lawyers and Mergermarket.

Amy Keller: Most Influential

Congratulations to our very own Amy Keller for being recognized by Mergers & Acquisitions as one of the Most Influential Women in Mid-Market M&A 2026.

Thought Leadership

Strategies for Winning Deals

A five-part video series on strategies for winning competitive M&A processes. Click here to watch the full series.

What’s Next for Global PE in 2026? More Exits and Creative Solutions

Five predictions on how global private equity activity is likely to evolve in 2026. Click here to read.

Debt Download

Our monthly newsletter covering what you need to know in the leveraged finance market. Click here to subscribe.

To keep up with our latest thought leadership, subscribe to our mailing list.

Deal Highlights

To stay up to date on our recent transactions, visit our Private Equity page under our News & Events section.

Bregal Sagemount on its exit from DentalXChange (“DXC”) following a successful strategic partnership.

Bridgepoint on its majority investment in Zuto, an FCA-regulated car finance broker operating across the UK.

Frazier Healthcare Partners on the sale of Elevate Patient Financial Solutions, a healthcare revenue cycle management provider, to Audax Private Equity and Parthenon Capital.

Novo Holdings A/S and KabaFusion, a leading provider of specialty infusion and home infusion pharmacy services, in the pending sale of KabaFusion to Nautic Partners.

Parquest and Allen’s management, a leading player in private wealth management and multi-family office services, on an agreement for Qualium Investissement to acquire a majority stake in the group.

Patron Capital on the acquisition of a majority stake by Mitsubishi Estate’s investment management business.

Stirling Square Capital Partners on its agreement to sell a minority stake in the Infobric Group, a construction software business, to KKR.

Summit Partners on the sale of its shares in ELATEC, a global provider of advanced identification and access control solutions, to Allegion PLC.

TA Associates on a strategic minority investment in Kline Hill Partners, an investment firm focused on the private equity secondaries market.

Templewater on its award-winning take-private acquisition of TalkMED Group, a Singapore-based oncology and specialty care provider, through its Tamarind Health platform.

Tinicum and its portfolio company PennAero on PennAero’s agreement to acquire the aerospace business of TriMas Corporation.

Webster Equity Partners and CenExel Clinical Research, Inc. (“CenExel”), a leading clinical trial site network focused on early-and late-phase research, in the sale of CenExel to BayPine.

Our Private Equity Practice

To learn more about how we can help, visit our expertise page or email privateequity@goodwinlaw.com.